Skip to main content

Table 2 Correlation of MG-H1 with follicular development, fertilization, embryonic development, and implantation in Hishi and control groups a

From: Trapa bispinosa Roxb. extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology: a randomized controlled trial

  Hishi group Control group
  r (n) p-value r (n) p-value
MG-H1 concentration in follicular fluid …
vs. number of follicles 12 mm on hCG day -0.38 (30) <0.05 -0.24 (29) 0.20
vs. number of oocytes retrieved -0.46 (30) <0.05 -0.22 (29) 0.26
vs. number of oocytes fertilized -0.47 (30) <0.01 -0.16 (29) 0.42
vs. number of day-2 embryos -0.41 (30) <0.05 -0.01 (29) 0.95
% increase of serum MG-H1 from pre-trial value
vs. % day-2 embryos per retrieved oocyte -0.45 (29) <0.05 -0.21 (30) 0.26
Pre-trial serum MG-H1 concentration …
vs. % superior day-2 embryos per day-2 embryo 0.37 (30) <0.05 -0.01 (30) 0.97
vs. endometrial thickness 0.11 (29) 0.56 -0.51 (30) <0.01
  1. a Correlations between % increase of serum MG-H1 and % day-2 embryos per retrieved oocyte, and between pre-trial serum MG-H1 and endometrial thickness in the Hishi group, were analyzed by the Pearson test; all other correlations were analyzed by the Spearman test